Is a complete BCBA/BIIBD research report available?

No complete published report is available for bcba/BIIBD (BCBA/BIIBD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/BIIBD (BCBA/BIIBD)

Buenos Aires Stock Exchange: BCBA/BIIBD · USD

$21.1

+0.64 (+3.1%)· Recorded snapshot

Market cap	55.6T
Revenue (ttm)	15.7T
Net income (ttm)	529.9B
EPS (ttm)	$277
P/E (trailing)	117.5x
P/E (forward)	16.1x
Volume	23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.7T
Net income (ttm): 529.9B
EPS (ttm): $277
P/E (trailing): 117.5x
P/E (forward): 16.1x
Market cap: 55.6T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-28
Employees	7,500
Employees change	-105
Employees growth	-1.38%
Enterprise value	$65.6T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-09-19
Fiscal year end	December
Founded	1978
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARBCOM4601A8
Last earnings date	2026-10-28
Last refreshed	2026-10-29
Market cap	$55.6T
Next earnings date	2026-10-29
Price	$21.11
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bcba/BIIBD
Website	https://www.biogen.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-28

Employees

7,500

Employees change

-105

Employees growth

-1.38%

Enterprise value

$65.6T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-09-19

Fiscal year end

December

Founded

1978

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARBCOM4601A8

Last earnings date

2026-10-28

Last refreshed

2026-10-29

Market cap

$55.6T

Next earnings date

2026-10-29

Price

$21.11

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

bcba/BIIBD

Website

https://www.biogen.com

Metric	Value
Average P/E ratio (10Y)	19.56x
Average P/E ratio (3Y)	27.63x
Average P/E ratio (5Y)	23.52x
Earnings yield	0.85%
EV/Earnings	123.52x
EV/EBIT	16.92x
EV/EBITDA	12.23x
EV/FCF	20.73x
EV/Sales	4.25x
FCF / EV yield	4.82%
FCF yield	5.69%
Forward P/E	16.12x
Graham number	7.05965
Graham upside	-66.56%
Lynch fair value	$1.01
Lynch upside	-95.22%
P/(FCF - SBC) ratio	20.57x
P/(OCF - SBC) ratio	18.7x
P/B ratio	1.92x
P/E ratio	117.47x
P/FCF ratio	17.56x
P/OCF ratio	16.19x
P/S ratio	3.53x
Price/EBITDA ratio	11.01x

Metric

Value

Average P/E ratio (10Y)

19.56x

Average P/E ratio (3Y)

27.63x

Average P/E ratio (5Y)

23.52x

Earnings yield

0.85%

EV/Earnings

123.52x

EV/EBIT

16.92x

EV/EBITDA

12.23x

EV/FCF

20.73x

EV/Sales

4.25x

FCF / EV yield

4.82%

FCF yield

5.69%

Forward P/E

16.12x

Graham number

7.05965

Graham upside

-66.56%

Lynch fair value

$1.01

Lynch upside

-95.22%

P/(FCF - SBC) ratio

20.57x

P/(OCF - SBC) ratio

18.7x

P/B ratio

1.92x

P/E ratio

117.47x

P/FCF ratio

17.56x

P/OCF ratio

16.19x

P/S ratio

3.53x

Price/EBITDA ratio

11.01x

Metric	Value
EBIT margin	23.5%
EBITDA margin	32.07%
Effective tax rate	21.93%
FCF margin	19.89%
Gross margin	75.77%
Operating margin	23.5%
Pretax margin	4.32%
Profit margin	3.37%
Profit per employee	$70.7M
Profitable quarters	2
Profitable years	22
Revenue per employee	$2.1B
ROA	4.94%
ROA (5Y)	6.68%
ROCE	8.6%
ROE	1.87%
ROE (5Y)	13.26%
ROIC	7.36%
ROIC (5Y)	13.87%
SBC / revenue	2.94%
Tax / revenue	0.95%

Metric

Value

EBIT margin

23.5%

EBITDA margin

32.07%

Effective tax rate

21.93%

FCF margin

19.89%

Gross margin

75.77%

Operating margin

23.5%

Pretax margin

4.32%

Profit margin

3.37%

Profit per employee

$70.7M

Profitable quarters

Profitable years

Revenue per employee

$2.1B

ROA

4.94%

ROA (5Y)

6.68%

ROCE

8.6%

ROE

1.87%

ROE (5Y)

13.26%

ROIC

7.36%

ROIC (5Y)

13.87%

SBC / revenue

2.94%

Tax / revenue

0.95%

Metric	Value
EPS growth	-78.71%
EPS growth 10Y	-18.32%
EPS growth 3Y	-38.52%
EPS growth 5Y	-25.55%
EPS growth years	0
FCF growth	-10.14%
FCF growth (Q)	-51.04%
FCF growth (QoQ)	47.16%
FCF growth 3Y	24.95%
FCF growth 5Y	-0.67%
Gross profit growth	17.87%
Gross profit growth (Q)	5.59%
Gross profit growth 3Y	1.29%
Gross profit growth 5Y	-3.16%
Net income growth	-78.4%
Net income growth 3Y	-38.05%
Net income growth 5Y	-25.81%
Net income growth years	0
OCF growth	-8.42%
OCF growth (Q)	-49.64%
OCF growth (QoQ)	42.75%
OCF growth 10Y	-5.71%
OCF growth 3Y	18.23%
OCF growth 5Y	-1.59%
Operating income growth	-17.05%
Operating income growth (Q)	-12.43%
Operating income growth 3Y	5.41%
Operating income growth 5Y	-1.08%
Revenue growth	2.3%
Revenue growth (Q)	10.63%
Revenue growth (QoQ)	2.49%
Revenue growth 10Y	-1.03%
Revenue growth 3Y	1%
Revenue growth 5Y	-1.49%
Revenue growth quarters	2
Revenue growth years	1

Metric

Value

EPS growth

-78.71%

EPS growth 10Y

-18.32%

EPS growth 3Y

-38.52%

EPS growth 5Y

-25.55%

EPS growth years

FCF growth

-10.14%

FCF growth (Q)

-51.04%

FCF growth (QoQ)

47.16%

FCF growth 3Y

24.95%

FCF growth 5Y

-0.67%

Gross profit growth

17.87%

Gross profit growth (Q)

5.59%

Gross profit growth 3Y

1.29%

Gross profit growth 5Y

-3.16%

Net income growth

-78.4%

Net income growth 3Y

-38.05%

Net income growth 5Y

-25.81%

Net income growth years

OCF growth

-8.42%

OCF growth (Q)

-49.64%

OCF growth (QoQ)

42.75%

OCF growth 10Y

-5.71%

OCF growth 3Y

18.23%

OCF growth 5Y

-1.59%

Operating income growth

-17.05%

Operating income growth (Q)

-12.43%

Operating income growth 3Y

5.41%

Operating income growth 5Y

-1.08%

Revenue growth

2.3%

Revenue growth (Q)

10.63%

Revenue growth (QoQ)

2.49%

Revenue growth 10Y

-1.03%

Revenue growth 3Y

Revenue growth 5Y

-1.49%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-269B
Depreciation and amortization	$1.4T
EBIT	$3.7T
EBITDA	$5T
EPS	$277.05
Financing cash flow	$1.1T
Free cash flow	$3.2T
Free cash flow minus SBC	$2.7T
Gross profit	$11.9T
Income taxes	$148.8B
Investing cash flow	$-8.4T
Net borrowing	$960.9B
Net cash flow	$-3.9T
Net income	$529.9B
Operating cash flow minus SBC	$3T
Operating income	$3.7T
Revenue	$15.7T
Stock-based compensation	$461.3B

Metric

Value

Capital expenditures

$-269B

Depreciation and amortization

$1.4T

EBIT

$3.7T

EBITDA

$5T

EPS

$277.05

Financing cash flow

$1.1T

Free cash flow

$3.2T

Free cash flow minus SBC

$2.7T

Gross profit

$11.9T

Income taxes

$148.8B

Investing cash flow

$-8.4T

Net borrowing

$960.9B

Net cash flow

$-3.9T

Net income

$529.9B

Operating cash flow minus SBC

$3T

Operating income

$3.7T

Revenue

$15.7T

Stock-based compensation

$461.3B

Metric	Value
Altman Z-Score	2.89
Book value per share	$195,225.37
Debt / EBITDA	2.28
Debt / equity	0.41
Debt / FCF	3.77
Goodwill	$10.8T
Interest coverage	7.94
Long-term assets	$37.2T
Long-term liabilities	$14T
Net cash (debt)	$-9.9T
Net cash / market cap	-17.86%
Net debt / EBITDA	1.97
Net debt / equity	0.34
Net debt / FCF	3.14
Piotroski F-Score	5
Property, plant and equipment	$4.8T
Shareholders' equity	$28.9T
Tangible book value	$-2.2T
Tangible book value per share	$-14,964.24
Total assets	$48.9T
Total cash	$2T
Total debt	$11.9T
Total liabilities	$20T

Metric

Value

Altman Z-Score

2.89

Book value per share

$195,225.37

Debt / EBITDA

2.28

Debt / equity

0.41

Debt / FCF

3.77

Goodwill

$10.8T

Interest coverage

7.94

Long-term assets

$37.2T

Long-term liabilities

$14T

Net cash (debt)

$-9.9T

Net cash / market cap

-17.86%

Net debt / EBITDA

1.97

Net debt / equity

0.34

Net debt / FCF

3.14

Piotroski F-Score

Property, plant and equipment

$4.8T

Shareholders' equity

$28.9T

Tangible book value

$-2.2T

Tangible book value per share

$-14,964.24

Total assets

$48.9T

Total cash

$2T

Total debt

$11.9T

Total liabilities

$20T

Metric	Value
Asset turnover	0.34
Current assets	$11.7T
Current liabilities	$6T
Current ratio	1.95
Inventory turnover	1.13
Net working capital	$4.2T
Quick ratio	0.95
Working capital	$5.6T
Working capital turnover	3,365.05

Metric

Value

Asset turnover

0.34

Current assets

$11.7T

Current liabilities

$6T

Current ratio

1.95

Inventory turnover

1.13

Net working capital

$4.2T

Quick ratio

0.95

Working capital

$5.6T

Working capital turnover

3,365.05

Metric	Value
Buyback yield / dilution	-1.49%
Shareholder yield	-1.49%

Metric

Value

Buyback yield / dilution

-1.49%

Shareholder yield

-1.49%

Metric	Value
150-day SMA	$15.64
1D price change	3.13%
1M price change	16.63%
1M total return	16.63%
1W price change	7.16%
1W total return	7.16%
1Y price change	92.43%
1Y return CAGR	92.52%
1Y total return	92.43%
20-day SMA	$18.92
200-day SMA	$14.42
3M price change	29.67%
3M total return	29.67%
3Y price change	-11.67%
3Y return CAGR	-4.05%
3Y total return	-11.67%
50-day SMA	$17.71
50-day SMA vs 200-day SMA	50over200
52-week high	$21.11
52-week high date	2026-10-28
52-week low	$11.52
52-week low date	2025-10-31
5Y price change	-0.89%
5Y return CAGR	-0.18%
5Y total return	-0.89%
6M price change	41.2%
6M total return	41.2%
All-time high	$30.50
All-time high date	2024-01-23
All-time low	$8.40
All-time low date	2025-04-21
Average true range (ATR)	$0.38
Average volume	40.1
Change from 52-week high	0%
Change from 52-week low	83.25%
Change from all-time high	-30.79%
Change from all-time low	151.31%
Change from open	2.98%
Day's gap	0.15%
Dollar volume	$486
High price	$21.11
Low price	$20.50
Monthly RSI	66.81
Open price	$20.50
Position in 52-week range	100%
Previous close	$20.47
Price vs 150-day SMA	34.97%
Price vs 20-day SMA	11.57%
Price vs 200-day SMA	46.35%
Price vs 50-day SMA	19.18%
Relative volume	0.57
RSI	75.37
Sharpe ratio	1.33
Sortino ratio	2.22
Volume	23
Weekly RSI	74.34
YTD price change	51.87%
YTD total return	51.87%

Metric

Value

150-day SMA

$15.64

1D price change

3.13%

1M price change

16.63%

1M total return

16.63%

1W price change

7.16%

1W total return

7.16%

1Y price change

92.43%

1Y return CAGR

92.52%

1Y total return

92.43%

20-day SMA

$18.92

200-day SMA

$14.42

3M price change

29.67%

3M total return

29.67%

3Y price change

-11.67%

3Y return CAGR

-4.05%

3Y total return

-11.67%

50-day SMA

$17.71

50-day SMA vs 200-day SMA

50over200

52-week high

$21.11

52-week high date

2026-10-28

52-week low

$11.52

52-week low date

2025-10-31

5Y price change

-0.89%

5Y return CAGR

-0.18%

5Y total return

-0.89%

6M price change

41.2%

6M total return

41.2%

All-time high

$30.50

All-time high date

2024-01-23

All-time low

$8.40

All-time low date

2025-04-21

Average true range (ATR)

$0.38

Average volume

40.1

Change from 52-week high

Change from 52-week low

83.25%

Change from all-time high

-30.79%

Change from all-time low

151.31%

Change from open

2.98%

Day's gap

0.15%

Dollar volume

$486

High price

$21.11

Low price

$20.50

Monthly RSI

66.81

Open price

$20.50

Position in 52-week range

100%

Previous close

$20.47

Price vs 150-day SMA

34.97%

Price vs 20-day SMA

11.57%

Price vs 200-day SMA

46.35%

Price vs 50-day SMA

19.18%

Relative volume

0.57

RSI

75.37

Sharpe ratio

1.33

Sortino ratio

2.22

Volume

Weekly RSI

74.34

YTD price change

51.87%

YTD total return

51.87%

Metric	Value
Float	147.2M
Shares change (QoQ)	-0.61%
Shares change (YoY)	1.49%
Shares held by insiders	0.21%
Shares held by institutions	97.64%
Short ratio	5.2 days

Metric

Value

Float

147.2M

Shares change (QoQ)

-0.61%

Shares change (YoY)

1.49%

Shares held by insiders

0.21%

Shares held by institutions

97.64%

Short ratio

5.2 days

BCBA/BIIBD (BCBA/BIIBD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/BIIBD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/BIIBD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/BIIBD

Frequently asked questions